FIELD: medicine.
SUBSTANCE: invention refers to medicine and may be used for treating anaemia or a red blood cell disorder in a patient having a condition, wherein the above condition is specified in a group consisting of sickle cell anaemia or rheumatoid disease. That is ensured by administering a therapeutically effective amount of lecithin cholesterol acyl transferase (LCAT) to the patient.
EFFECT: invention makes it possible to increase red blood cell weight and count in the patients suffering sickle cell anaemia and rheumatoid disease.
6 cl, 3 dwg, 2 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MATERIALS AND METHODS FOR METABOLISM MODULATION | 2005 |
|
RU2387445C2 |
| COMPOSITIONS WHICH POISSESS LIPID-REDUCING PROPERTIES | 2006 |
|
RU2428973C2 |
| TREATMENT AND PREVENTION METHOD OF GRAM-POSITIVE BACTERIA INDUCED DISEASES | 2006 |
|
RU2391985C2 |
| PHOSPHOLIPID THERAPEUTIC COMPOSITION WITH NANO-SIZED PARTICLES FOR LIPID STORAGE DISEASE AND COMATOSE STATES AND METHOD FOR PREPARING IT | 2010 |
|
RU2448715C1 |
| COMPOSITIONS CONTAINING 15-HEPE FOR TREATING OR PREVENTING HEMATOLOGICAL DISORDERS AND/OR RELATED DISEASES | 2020 |
|
RU2833560C1 |
| USE OF 2-PHENYL-3-AROYLBENZOTHIOPHENES FOR SERUM BLOOD CHOLESTEROL DECREASE, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2150275C1 |
| METADICHOL-LIQUID AND GEL NANO-DRUGS | 2014 |
|
RU2736752C2 |
| METADIHOL® - LIQUID AND GEL NANOLARTICAL PREPARATIONS | 2014 |
|
RU2631600C2 |
| METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION AND ISCHEMIC DAMAGE | 2012 |
|
RU2638807C2 |
| BACTERIAL COMPOSITIONS FOR PREVENTING AND TREATING DEGENERATIVE DISEASE | 2010 |
|
RU2571211C2 |
